Brains Bioceutical Announces the Addition of Industry Veteran John Boshart to its Animal Health Division
06 mai 2024 06h00 HE
|
Brains Bioceutical Corp
VANCOUVER, British Columbia, May 06, 2024 (GLOBE NEWSWIRE) -- Today marks a pivotal development for Brains Bioceutical Corp ("Brains Bio"), as it significantly strengthens its Veterinary Health...
Brains Bioceutical Corp, the Global Leader in Natural Cannabinoid APIs, Introduces Revolutionary Solid THC, Ushering in a New Era of Clinical Research
05 mars 2024 01h00 HE
|
Brains Bioceutical Corp
Vancouver, Canada & London, United Kingdom, March 05, 2024 (GLOBE NEWSWIRE) -- Brains Bioceutical Corp (“Brains Bio” or the “Company”), Brains Bio, a pioneer in the cannabinoid-based...
Prati-Donaduzzi Secures the Largest Global Pharma Supply Agreement for Natural Cannabinoids with API Manufacturer Brains Bioceutical
04 avr. 2023 01h00 HE
|
Brains Bioceutical Corp
VANCOUVER, British Columbia, April 04, 2023 (GLOBE NEWSWIRE) -- Brains Bioceutical Corp (“Brains Bio” or the “Company”), the largest natural cannabinoid active pharmaceutical ingredient (“API”)...
Brains Bio Receives NSF’s First CBD Certification for EU GMP CBD API
22 nov. 2022 06h00 HE
|
Brains Bioceutical Corp
VANCOUVER, British Columbia, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Brains Bioceutical Corp ("Brains Bio" or the "Company"), a global leader in EU GMP grade Cannabidiol (CBD) has received NSF GMP...
Brains Bioceutical Opens UK’s Largest EU GMP-Grade Licensed Cannabinoid Research and Commercial Production Facility
29 sept. 2022 01h00 HE
|
Brains Bioceutical Corp
VANCOUVER, British Columbia and SANDWICH, United Kingdom, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Brains Bioceutical Corp (“Brains” or the “Company”), is pleased to announce the opening of its recently...
Brains Bioceutical Inaugura a Maior Instalação de Pesquisa e Produção Comercial de Canabinóides Licenciados de Grau BPF da UE no Reino Unido
29 sept. 2022 01h00 HE
|
Brains Bioceutical Corp
VANCOUVER, British Columbia e SANDWICH, Reino Unido, Sept. 29, 2022 (GLOBE NEWSWIRE) -- A Brains Bioceutical Corp (“Brains” ou a “Empresa”) tem o prazer de anunciar a inauguração da sua instalação...
Brains Bioceutical inaugura la mayor instalación de investigación y producción comercial de cannabinoides con licencia de grado BPF de la UE en el Reino Unido
29 sept. 2022 01h00 HE
|
Brains Bioceutical Corp
VANCOUVER, Columbia Británica y SANDWICH, Reino Unido, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Brains Bioceutical Corp (“Brains” o la “Empresa”), se complace en anunciar la inauguración de su...
Brains Bioceutical Corp. logra un aumento de capital de 31,9 millones de USD con el inversor principal DSM Venturing
17 juin 2021 16h51 HE
|
Brains Bioceutical Corp
VANCOUVER, Columbia Británica, June 17, 2021 (GLOBE NEWSWIRE) -- Brains Bioceutical Corp. (en adelante, «Brains» o la «Empresa») se complace en anunciar la consecución de un aumento de capital...
Brains Bioceutical Corp. führt Kapitalbeschaffungsmaßnahme in Höhe von 31,9 Millionen US-Dollar mit Leadinvestor DSM Venturing durch
17 juin 2021 16h51 HE
|
Brains Bioceutical Corp
VANCOUVER, British Columbia, June 17, 2021 (GLOBE NEWSWIRE) -- Brains Bioceutical Corp. („Brains“ oder das „Unternehmen“) freut sich, den Abschluss einer Kapitalbeschaffungsmaßnahme in Höhe von 31,9...
Brains Bioceutical Corp. rondt een kapitaalverhoging van USD $31,9 miljoen af met lead investor DSM Venturing
17 juin 2021 16h51 HE
|
Brains Bioceutical Corp
VANCOUVER, British Columbia, June 17, 2021 (GLOBE NEWSWIRE) -- Brains Bioceutical Corp. ("Brains" of het "Bedrijf") is verheugd de voltooiing te kunnen aankondigen van een kapitaalverhoging van USD...